Drugmaker AstraZeneca said on Friday that its Imfinzi asset has been approved in the EU as the first and only perioperative ...

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer.

Shaw's remarks come after Siddaramaiah defended his decision to order an inquiry into recent heart-related deaths in Hassan.

Aptamer Group, a developer of synthetic binders delivering innovation to the life science industry, says it is raising £2m by ...

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

Bond yields hold steady, electric car sales rise in June - Stock markets updates and business news from Friday ...